Keyphrases
COVID-19
100%
Meta-analysis
48%
Vaccination
44%
Indonesia
39%
COVID-19 Vaccine
32%
Avian Influenza
31%
Systematic Meta-analysis
24%
Antibody Response
23%
Healthcare Workers
23%
Severe Coronavirus Disease 2019
21%
Whole-cell Vaccine
18%
SARS-CoV-2 Infection
16%
Immune Response
16%
Hypertension
15%
Lung Adenocarcinoma
15%
Circulating Tumor DNA (ctDNA)
15%
Live Poultry Market
15%
Systemic Lupus Erythematosus
15%
Heligmosomoides Polygyrus
15%
Mortality Risk
15%
Network Meta-analysis
15%
Global Prevalence
15%
SARS-CoV-2 Vaccine
15%
Co-infection
15%
Lung
14%
Lung Tissue
14%
Type 1 Diabetes Mellitus (T1DM)
13%
Balb C Mice
13%
Influenza A/H5N1 Virus
13%
Virus
12%
A(H5N1)
12%
EGFR mutation
12%
East Java Indonesia
12%
PubMed
11%
MRNA Vaccine
11%
COVID-19 Vaccination
11%
Highly Pathogenic Avian Influenza Viruses (HPAIV)
11%
Serum IgE
11%
IgG Levels
11%
Histopathological Changes
10%
Macrophage Polarization
10%
Cytokine Storm
10%
Messenger RNA (mRNA)
10%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
10%
Mycobacterium Tuberculosis Infection
10%
Poultry
9%
Vaccination Program
9%
Adverse Effects
9%
Epidermal Growth Factor Receptor
9%
Retrospective Cohort Study
9%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
91%
Coronavirinae
77%
Vaccination Policy
54%
COVID-19 Vaccine
41%
Infection
41%
SARS Coronavirus
31%
Prevalence
25%
Epidermal Growth Factor Receptor
18%
Liver Injury
15%
Lung Adenocarcinoma
15%
Randomized Controlled Trial
13%
Diabetes Mellitus
13%
Avian Influenza (H5N1)
13%
mRNA Vaccine
11%
Influenza A Virus (H5N1)
11%
Adverse Event
11%
RNA
11%
Cohort Study
10%
Highly Pathogenic Avian Influenza
10%
Bagg Albino Mouse
10%
Epidermal Growth Factor Receptor Kinase Inhibitor
9%
Virus Vaccine
9%
Inactivated Virus Vaccine
9%
Interleukin 6
9%
Symptom
9%
Cytokine Storm
8%
Circulating Tumor DNA
7%
DRESS Syndrome
7%
Avian Influenza
7%
Systemic Lupus Erythematosus
7%
Asymptomatic Infection
7%
Acute Lung Injury
7%
Bird
7%
Myocarditis
7%
Probiotic Agent
7%
Occludin
7%
Polysaccharide
7%
Tuberculostatic Agent
7%
Lung Injury
7%
Neoplasm
7%
Pneumonia
7%
Thrombosis
7%
Frailty
7%
Alpha Tocopherol
7%
Lung Tuberculosis
7%
Virus Infection
7%
Mortality Rate
6%
DNA
6%
Mouse
5%
Medical History
5%
Medicine and Dentistry
COVID-19
81%
Infection
52%
Severe Acute Respiratory Syndrome Coronavirus 2
35%
COVID-19 Vaccine
33%
Meta-Analysis
32%
Systematic Review
23%
Immune Response
19%
Prevalence
16%
Liver Injury
15%
Antibody Response
15%
Mixed Infection
15%
Heligmosomoides polygyrus
15%
Epidermal Growth Factor Receptor
14%
Disease
13%
COVID-19 Vaccination
13%
Randomized Controlled Trial
12%
Tuberculosis
12%
Immunosenescence
11%
mRNA Vaccine
11%
Health Care
11%
Adverse Event
9%
Macrophage
9%
Enzyme Linked Immunosorbent Assay
9%
Nematoda
9%
Mycobacterium Tuberculosis
8%
Macrophage Polarization
8%
Immune System
8%
Interleukin 6
8%
Virus Vaccine
8%
Quality of Life
7%
Hope
7%
DRESS Syndrome
7%
Diphtheria Toxoid CRM197
7%
Pneumococcus Polysaccharide
7%
Liquid Biopsy
7%
Vasculotropin A
7%
Mesenchymal Stem Cell
7%
Pleura Effusion
7%
Tuberculostatic Agent
7%
Gene Mutation
7%
Blood Plasma
7%
Blood Donor
7%
Exon
7%
Frailty
7%
Diagnosis
7%
Pneumonia
7%
Retrospective Cohort Study
7%
Thrombosis
7%
Pre-Eclampsia
7%
Seroconversion
7%